CCM
TECH icon

Cinctive Capital Management’s Bio-Techne TECH Stock Holding History

Cinctive Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.53M Buy
+78,335
New +$4.23M 0.2% 158
2022
Q3 		– Sell
-49,348
Closed -$4.28M – 611
2022
Q2 		$4.28M Buy
49,348
+12,512
+34% +$1.17M 0.18% 184
2022
Q1 		$3.99M Buy
+36,836
New +$3.8M 0.15% 226
2021
Q2 		– Sell
-12,648
Closed -$1.21M – 605
2021
Q1 		$1.21M Buy
+12,648
New +$1.15M 0.07% 319

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cinctive Capital Management's TECH Position: Q2 2026 in Review

Cinctive Capital Management opened a new position in Bio-Techne (TECH) in Q2 2026: 78,335 shares worth $5.53M. The stake represents 0.2% of the portfolio and ranks #158 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in TECH as recently as Q2 2022.

Cinctive Capital Management first reported a position in TECH in Q1 2021 and has held it in 4 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Cinctive Capital Management held 78,335 shares of Bio-Techne worth $5.53M as of Q2 2026.
  • Bio-Techne was a new Cinctive Capital Management position in Q2 2026.
  • Bio-Techne made up 0.2% of Cinctive Capital Management's portfolio in Q2 2026, its #158 holding.
  • Cinctive Capital Management first reported a position in Bio-Techne in Q1 2021 and has held it in 4 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.